Miniatura

Fitxers

884631.pdf (2.67 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2024-10-03

Llicència de publicació

cc-by-nc-nd (c) Terkelsen, Miriam H. et al., 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/221142

Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1111/ene.16503

Resum

Background and purpose: Most patients with isolated rapid eye movement sleep behaviour disorder (iRBD) progress to a parkinsonian alpha-synucleinopathy. However, time to phenoconversion shows great variation. The aim of this study was to investigate whether cholinergic and dopaminergic dysfunction in iRBD patients was associated with impending phenoconversion. Methods: Twenty-one polysomnography-confirmed iRBD patients underwent baseline 11C-donepezil and 6-Fluoro-(18F)-l-3,4-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET). Potential phenoconversion was monitored for up to 8 years. PET images were analysed according to patients' diagnoses after 3 and 8 years using linear regression. Time-to-event analysis was made with Cox regression, dividing patients into low and high tracer uptake groups. Results: Follow-up was accomplished in 17 patients. Eight patients progressed to either Parkinson's disease (n = 4) or dementia with Lewy bodies (n = 4), while nine remained non-phenoconverters. Compared with non-phenoconverters, 8-year phenoconverters had lower mean 11C-donepezil uptake in the parietal (p = 0.032) and frontal cortex (p = 0.042), whereas mean 11C-donepezil uptake in 3-year phenoconverters was lower in the parietal cortex (p = 0.005), frontal cortex (p = 0.025), thalamus (p = 0.043) and putamen (p = 0.049). Phenoconverters within 3 years and 8 years had lower 18F-DOPA uptake in the putamen (p < 0.001). iRBD patients with low parietal 11C-donepezil uptake had a 13.46 (95% confidence interval 1.42;127.21) times higher rate of phenoconversion compared with those with higher uptake (p = 0.023). iRBD patients with low 18F-DOPA uptake in the most affected putamen were all phenoconverters with higher rate of phenoconversion (p = 0.0002). Conclusions: These findings suggest that cortical cholinergic dysfunction, particularly within the parietal cortex, could be a biomarker candidate for predicting short-term phenoconversion in iRBD patients. This study aligns with previous reports suggesting dopaminergic dysfunction is associated with forthcoming phenoconversion.

Matèries

Dopamina, Tomografia per emissió de positrons, Receptors colinèrgics, Trastorns del son, Malaltia de Parkinson

Matèries (anglès)

Dopamine, Positron emission tomography, Acetylcholine receptors, Sleep disorders, Parkinson's disease

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

TERKELSEN, Miriam h., IRANZO, Alex, SERRADELL, Mónica, BAUN, Andreas m., STOKHOLM, Morten g., DANIELSEN, Erik hvid, ØSTERGAARD, Karen, OTTO, Maritt, SVENDSEN, Kristina b., MØLLER, Mette, JOHNSEN, Erik l., GARRIDO, Alicia, VILAS ROLÁN, Dolores, SANTAMARIA CANO, Joan, MØLLER, Arne, GAIG VENTURA, Carles, BROOKS, David j., BORGHAMMER, Per, TOLOSA, Eduardo, PAVESE, Nicola. Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion. _European Journal of Neurology_. 2024. Vol. 31, núm. 12. [consulta: 24 de gener de 2026]. ISSN: 1351-5101. [Disponible a: https://hdl.handle.net/2445/221142]

Exportar metadades

JSON - METS

Compartir registre